(Q34501896)

2 August 2017

1 reference

title

How strong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review (English)

1 reference

2 August 2017

1 reference

1 reference

1 reference

Zarko Alfirevic

1

1 reference

2 August 2017

Devender Roberts

series ordinal

2

1 reference

2 August 2017

Vanessa Martlew

series ordinal

3

1 reference

2 August 2017

publication date

1 February 2002

1 reference

European Journal of Obstetrics Gynecology and Reproductive Biology

2 August 2017

published in

1 reference

2 August 2017

volume

101

1 reference

2 August 2017

issue

1

1 reference

2 August 2017

page(s)

6-14

1 reference

Screening for lupus anticoagulant and anticardiolipin antibodies in women with fetal loss

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

Increased fetal loss in women with heritable thrombophilia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

Increased frequency of genetic thrombophilia in women with complications of pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

Changes in homocysteine levels during normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

Hyperhomocysteinaemia and protein S deficiency in complicated pregnancies.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

Hyperhomocysteinemia: a risk factor for placental abruption or infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

Resistance to activated protein C and the leiden mutation: high prevalence in patients with abruptio placentae

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

High prevalence of activated protein C resistance due to factor V leiden mutation in cases of intrauterine fetal death.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of preeclampsia or fetal growth restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

Underlying disorders associated with severe early-onset preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

The factor V Leiden mutation may predispose women to severe preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

The factor V Leiden mutation is not a common cause of pregnancy-induced hypertension in Japan

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

Preeclampsia is associated with a reduced response to activated protein C

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

Factor V Leiden and thermolabile methylenetetrahydrofolate reductase gene variants in an East Anglian preeclampsia cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

Activated protein C resistance shows an association with pregnancy-induced hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

Preeclampsia and genetic risk factors for thrombosis: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

Methylenetetrahydrofolate reductase polymorphism and pre-eclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

Hemostatic abnormalities may predict chronic hypertension after preeclampsia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-2115%2801%2900496-1

7 January 2021

10.1016/S0301-2115(01)00496-1

Identifiers

DOI

1 reference

2 August 2017

1 reference